Now showing items 1-12 of 12

      Financiación
      The authors would like to thank the Spanish Ministry of Health and Consumption (Carlos III Institute of Health. FIS. Grant PI 051579). D. Martínez-Gómez receives a predoctoral fellowship from the Spanish Ministry of Education and Science (AP2006-02464). M.A. Puertollano owned a research contract ("Juan de la Cierva") from the Spanish Ministry of Education and Science. The EVASYON study has received the award from AESAN (Spanish Agency for Food Security and Nutrition) from the Spanish Ministry of Health and Consumption to the best applied research project in 2009. [1]
      This study was granted by Spanish Ministry of Innovation and Science. Junta de Andalucía: Excellence Projects (P06-CTS-02341); Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-01); Research post-doctoral fellowship from the Alfonso Martín Escudero Foundation; MyNewGut FP7 EU Project (Grant agreement n° 613979); DynaHEALTH EU Project HORIZON 2020 (Grant agreement n°: 633595-2); Marie Curie post-doctoral fellowship (FP7, no. 329812, NutriOmics); The first author received Post Doc scholarships from Henning and Johan Throne-Holst’s foundation, and the Swedish Research Council for Health, Working life and Welfare (FORTE, ref 2014–2648). [1]
      This project has been funded by Ordesa Laboratories, S.L. Contract University of Granada General Foundation, No. 3349 and SMARTFOODS (CIEN) Contract University of Granada General Foundation, No. 4003, Spanish Ministry of Economy, Industry and Competitiveness; funded in part by HORIZON 2020 EU DynaHEALTH Project (GA No.633595). [1]
      This project received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633595 [1]
      This research was funded by the European Commission (DynaHEALTH-HORIZON 2020GANo: 633595) and the Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-02). Further support was obtained from, Spanish Ministry of Innovation and Science (Junta de Andalucía), Excellence Projects (P06-CTS-02341). ADLGP thanks the Mexican government and the National Council on Science and Technology (CONACYT) for her PhD grant. The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. [1]
      This study received financial assistance from the following: Ciberehd, Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III. ISCIII, Proyecto del Plan Nacional I+D+i 2013-2016 (PI13/01925), Confinanciacio´n Fondos FEDER. Gilead Fellowship Program (GLD14-00292 and GLD15-00307). [1]
      This study was funded by Spanish Ministry of Innovation and Science. Junta de Andalucía: Excellence Projects (P06-CTS-02341); Spanish Ministry of Education (Grant no. SB2010-0025); Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-01); Further support was received by Abbott Laboratories, Granada, Spain. [1]
      This work was funded by Biosearch Life supported by a grant from the Agency of Innovation and Development of Andalusia (IDEA-Spain), Cofinanced by European Regional Development Fund (EC). Project Tittle: “New applications of probiotic strains and derived compounds with biological activity (POSTBIO)” and partially funded by Lactalis-Puleva (Granada, Spain). [1]
      This work was supported by Spanish Ministry of Innovation and Science. Junta de AndalucõÂa: Excellence Projects (P06-CTS-02341 [to CC]); Spanish Ministry of Education (Grant no. SB2010- 0025 [to CC]); Spanish Ministry of Economy and Competitiveness (BFU2012-40254- C03-01 [to CC]); Abbott Laboratories, Granada, Spain; Henning and Johan Throne-Holst's foundation (Post Doc scholarship [to SKB]). [1]
      This work was supported by the European Union’s Horizon 2020 research and innovation program [grant agreement no. 633595 DynaHEALTH] and no. 733206 LifeCycle], the Netherlands Organization for Health Research and Development [ZONMW Vici project 016.VICI.170.200]. The PREOBE cohort was funded by Spanish Ministry of Innovation and Science. Junta de Andalucía: Excellence Projects (P06-CTS-02341) and Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-01). The first phase of the Generation R Study is made possible by financial support from the Erasmus Medical Centre, the Erasmus University, and the Netherlands Organization for Health Research and Development (ZonMW, grant ZonMW Geestkracht 10.000.1003). The Northern Finland Birth Cohort 1986 is funded by University of Oulu, University Hospital of Oulu, Academy of Finland (EGEA), Sigrid Juselius Foundation, European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NIH/NIMH (5R01MH63706:02) [1]
      This work was supported by the European Union’s 7th Framework Programme under grant agreement No. 613979 (MyNewGut Project 2013/KB/613979) [1]
      Tomás Cerdó participated in the Ph.D. Program in Biomedicine of the University of Granada and is a fellow of the FPI (BES-2013-065133) program at the Spanish Ministry of Economy and Competitiveness. [1]